Skip to content
Neuromyelitis News logo
  • About NMOSD
    What is NMOSD?
    Causes
    Symptoms
    Diagnosis
  • Treatments
    Approved treatments
  • News
  • Columns
    The Beginner’s Guide to Walking — Jennifer V.
    Archived Columns
    • Courage to Care — Candice Galvan
    • Strength of the Soul — Mileidys Almaguer Iniguez
    • The View From Here — Lelainia Lloyd
  • NMO spotlight
  • What can we help you find today?

June 18, 2021 News by Mary Chapman

Get Ready for NORD’s Patient and Family Forum, Set for June 26-27

Those who wish to gain practical tools for living optimally with rare diseases are encouraged to attend the annual Living Rare Living Stronger Patient and Family Forum, hosted by the National Organization for Rare Disorders (NORD) and set this year for June 26-27. The conference brings together patients,…

February 17, 2021 News by Marta Figueiredo, PhD

Eurordis Survey: Healthcare Experience Worse for Rare Disease Patients

People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of an international survey conducted by Eurordis-Rare Diseases Europe. Indeed, rare disease patients overall give their healthcare experience a medium-low rating, of 2.5 on a scale of 1 to 5,…

January 27, 2021 News by ForestRay

COVID-19 Vaccines Pose Little Risk to Rare Disease Patients, FDA, CDC Say

The two COVID-19 vaccines that recently received emergency approval from the U.S. and other worldwide regulatory agencies are expected to pose little risk to the rare disease community, including to patients with compromised immune systems or those participating in gene therapy studies. That was the message of a recent…

  • Previous Prev
  • 1
  • 2
  • 3
  • Previous Prev

Recent Posts

  • Enspryng helps patients remain relapse-free after 6 months: Study
  • For me, preventing relapses involves harsh medication side effects
  • Smoking tied to disability risk in AQP4-NMOSD patients: Study
  • I have NMOSD, and I want to climb a volcano
  • Blood cell ratio may be biomarker of NMOSD disability: Study
  • Off-label tocilizumab works better when taken after 1st attack: Study
  • What’s the difference between generic and brand-name drugs?
  • Switching doctors with NMOSD: When and how to do it
  • Regular rituximab treatment lessens NMOSD relapses: Real-world data
  • After a difficult year due to NMOSD, it’s time to address my mental health


Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.